OncoSil Medical Ltd News

OncoSil Medical Ltd Announces Capital Raising

TipRanksAug 6 20:19 ET

OncoSil Medical Achieves Strong Revenue Growth

TipRanksJul 31 01:10 ET

OncoSil Medical Gets AU$2.7 Million Investment for Building Distribution Network

MT NewswiresJul 25 01:17 ET

OncoSil Medical Shares Pancreatic Cancer Advances

TipRanksJul 23 01:47 ET

OncoSil Medical Discloses Shareholder Concentration

TipRanksJul 9 22:47 ET

OncoSil Medical Treats Fifth Pancreatic Cancer Patient With Proprietary Device

MT NewswiresJun 10 20:09 ET

Oncosil Medical Treats 200th Pancreatic Cancer Patient With Proprietary Device

MT NewswiresJun 2 21:07 ET

OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial

MT NewswiresApr 17 18:52 ET

OncoSil Medical Treats First Commercial Patient in Turkey With Implantable Pancreatic Cancer Device

MT NewswiresApr 15 20:53 ET

OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study

MT NewswiresApr 11 23:29 ET

OncoSil Medical Obtains Device Reimbursement Approval in UK

MT NewswiresApr 8 22:19 ET

First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device

MT NewswiresApr 4 18:52 ET

Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer

MT NewswiresMar 19 23:02 ET

Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade

MT NewswiresFeb 1 00:45 ET

OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%

MT NewswiresJan 31 23:45 ET

OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%

MT NewswiresJan 31 23:11 ET

OncoSil Device Draws Interest From 84 German Hospitals as Funding Talks Begin

The Market HeraldJan 31 21:44 ET

OncoSil Medical Receives AU$1.1 Million R&D Tax Rebate

MT NewswiresDec 15, 2023 02:23 ET

Stocks of the Hour: Lincoln Minerals, OncoSil Medical, Avira Resources

sharecafeDec 7, 2023 19:50 ET

First Patient Treated in OncoSil Medical's Pancreatic Cancer Drug Trial

MT NewswiresNov 28, 2023 23:49 ET